keyword
https://read.qxmd.com/read/38522596/histamine-and-receptors-in-neuroinflammation-their-roles-on-neurodegenerative-diseases
#21
REVIEW
Zhenyu Zhou, Qi An, Wanying Zhang, Yixin Li, Qihang Zhang, Haijing Yan
Histamine, an auto-reactive substance and mediator of inflammation, is synthesized from histidine through the action of histidine decarboxylase (HDC). It primarily acts on histamine receptors in the central nervous system (CNS). Increasing evidence suggests that histamine and its receptors play a crucial role in neuroinflammation, thereby modulating the pathology of neurodegenerative diseases. Recent studies have demonstrated that histamine regulates the phenotypic switching of microglia and astrocytes, inhibits the production of pro-inflammatory cytokines, and alleviates inflammatory responses...
March 22, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38509244/optimizing-antithrombotic-therapy-in-patients-with-coexisting-cardiovascular-and-gastrointestinal-disease
#22
REVIEW
Azita H Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John W Eikelboom, Deborah M Siegal, Manuel Monreal, David Jimenez, Muthiah Vaduganathan, Lana A Castellucci, Adam Cuker, Geoffrey D Barnes, Jean M Connors, Eric A Secemsky, Benjamin W Van Tassell, Raffaele De Caterina, Jacob E Kurlander, Ali Aminian, Gregory Piazza, Samuel Z Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J Kirtane, Mitchell S V Elkind, Dominick J Angiolillo, Stavros Konstantinides, Gregory Y H Lip, Gregg W Stone, Mary Cushman, Harlan M Krumholz, Roxana Mehran, Deepak L Bhatt, Behnood Bikdeli
Balancing the safety and efficacy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the potential for interference with the absorption of antithrombotic drugs and for an increased risk of bleeding. In this Review, we address considerations for enteral antithrombotic therapy in patients with cardiovascular disease and gastrointestinal comorbidities. For those with gastrointestinal bleeding (GIB), we summarize a general scheme for risk stratification and clinical evidence on risk reduction approaches, such as limiting the use of concomitant medications that increase the risk of GIB and the potential utility of gastrointestinal protection strategies (such as proton pump inhibitors or histamine type 2 receptor antagonists)...
March 20, 2024: Nature Reviews. Cardiology
https://read.qxmd.com/read/38509098/structural-basis-of-ligand-recognition-and-design-of-antihistamines-targeting-histamine-h-4-receptor
#23
JOURNAL ARTICLE
Ruixue Xia, Shuang Shi, Zhenmei Xu, Henry F Vischer, Albert D Windhorst, Yu Qian, Yaning Duan, Jiale Liang, Kai Chen, Anqi Zhang, Changyou Guo, Rob Leurs, Yuanzheng He
The histamine H4 receptor (H4 R) plays key role in immune cell function and is a highly valued target for treating allergic and inflammatory diseases. However, structural information of H4 R remains elusive. Here, we report four cryo-EM structures of H4 R/Gi complexes, with either histamine or synthetic agonists clobenpropit, VUF6884 and clozapine bound. Combined with mutagenesis, ligand binding and functional assays, the structural data reveal a distinct ligand binding mode where D943.32 and a π-π network determine the orientation of the positively charged group of ligands, while E1825...
March 20, 2024: Nature Communications
https://read.qxmd.com/read/38504832/antihistamine-and-wound-healing-potential-of-gold-nanoparticles-synthesized-using-bulbine-frutescens-l-willd
#24
JOURNAL ARTICLE
Marizé Cuyler, Danielle Twilley, Velaphi C Thipe, Vusani Mandiwana, Michel L Kalombo, Suprakas S Ray, Rirhandzu Shamaine Rikhotso-Mbungela, Arno Janse van Vuuren, Will Coetsee, Kattesh V Katti, Namrita Lall
BACKGROUND: Atopic dermatitis (eczema) is an inflammatory skin condition with synthetic treatments that induce adverse effects and are ineffective. One of the proposed causes for the development of the condition is the outside-in hypothesis, which states that eczema is caused by a disruption in the skin barrier. These disruptions include developing dry cracked skin, which promotes the production of histamine. Bulbine frutescens (BF) is traditionally used to treat wounds and eczema; however, limited research has been conducted to scientifically validate this...
2024: Nanotechnology, Science and Applications
https://read.qxmd.com/read/38499162/efficacy-of-drugs-acting-on-histamine-1-receptors-in-irritable-bowel-syndrome-systematic-review-and-meta-analysis
#25
JOURNAL ARTICLE
Mais Khasawneh, Christopher J Black, Alexander C Ford
No abstract text is available yet for this article.
March 16, 2024: Gastroenterology
https://read.qxmd.com/read/38483045/the-role-of-histamine-h-1-receptor-in-the-anterior-cingulate-cortex-on-nociception-level-following-acute-restraint-stress-in-male-rats
#26
JOURNAL ARTICLE
Roxana Daniali, Fatemeh Zeraati, Mozhdeh Mohammadi, Rasool Haddadi
Considering the importance of pain and stress, we decided to investigate the intra-anterior cingulate cortex (ACC) microinjection of histamine and mepyramine alone and concurrently on acute pain induced by hot plate following restraint stress in male rats. 24-gauge, 10 mm stainless steel guide cannula was implanted over the ACC in the incised scalp of 4 groups. Restraint stress in healthy rats produced a significant increase (p < .05) in the pain threshold. The simultaneous microinjection of 4 μg/side histamine and 8 μg/side mepyramine as a histaminergic system inverse agonist in healthy nonrestraint animals did not affect the pain threshold...
April 2024: Pharmacology Research & Perspectives
https://read.qxmd.com/read/38468192/rebamipide-prevents-the-hemoglobin-drop-related-to-mucosal-damaging-agents-at-a-level-comparable-to-proton-pump-inhibitors
#27
JOURNAL ARTICLE
Ji Eun Kim, Yeong Chan Lee, Tae Se Kim, Eun Ran Kim, Sung Noh Hong, Young-Ho Kim, Kyunga Kim, Dong Kyung Chang
BACKGROUND/AIMS: : The effect of proton pump inhibitors (PPIs) on the lower gastrointestinal (GI) tract is uncertain, with potential to worsen damage. This study aimed to find the best method for protecting the entire GI tract from mucosal damage. METHODS: : A retrospective cohort study at Samsung Medical Center (2002-2019) included 195,817 patients prescribed GI mucosa-damaging agents. The primary goal was to assess the effectiveness of GI protective agents in preventing significant hemoglobin drops (>2 g/dL), indicating overall GI mucosal damage...
March 12, 2024: Gut and Liver
https://read.qxmd.com/read/38467503/effect-of-moxibustion-on-colonic-low-grade-inflammatory-response-in-rats-with-diarrhea-predominant-irritable-bowel-syndrome-based-on-mast-cell-degranulation
#28
JOURNAL ARTICLE
Ming Fang, Haoran Chu, Xiaoge Song, Jingru Ruan, Ling Zou, Kuiwu Li, Lumin Liao, Wenli Ma, Xiaoyu Han, Jingwei Zhu, Ziye Wang, Yucheng Fang
OBJECTIVES: To observe the effects of moxibustion on colonic mast cell degranulation and inflammatory factor expression in rats with diarrhea-predominant irritable bowel syndrome (IBS-D), and explore the potential mechanism of moxibustion in treating IBS-D. METHODS: Forty-five rat pups born from 5 healthy SPF-grade pregnant SD rats, with 8 rats were randomly selected as the normal group. The remaining 37 rats were intervened with maternal separation, acetic acid enema, and chronic restraint stress to establish the IBS-D model...
March 12, 2024: Zhongguo Zhen Jiu, Chinese Acupuncture & Moxibustion
https://read.qxmd.com/read/38458750/function-of-mast-cell-and-bile-cholangiocarcinoma-interplay-in-cholangiocarcinoma-microenvironment
#29
JOURNAL ARTICLE
Anda Shi, Zengli Liu, Zhongqi Fan, Kangshuai Li, Xingkai Liu, Yongchang Tang, Jiaming Hu, Xingyong Li, Lizhuang Shu, Liming Zhao, Lingling Huang, Zhiyue Zhang, Guoyue Lv, Zongli Zhang, Yunfei Xu
OBJECTIVE: The correlation between cholangiocarcinoma (CCA) progression and bile is rarely studied. Here, we aimed to identify differential metabolites in benign and malignant bile ducts and elucidate the generation, function and degradation of bile metabolites. DESIGN: Differential metabolites in the bile from CCA and benign biliary stenosis were identified by metabonomics. Biliary molecules able to induce mast cell (MC) degranulation were revealed by in vitro and in vivo experiments, including liquid chromatography-mass spectrometry (MS)/MS and bioluminescence resonance energy transfer assays...
March 8, 2024: Gut
https://read.qxmd.com/read/38440987/4-oxypiperidine-ethers-as-multiple-targeting-ligands-at-histamine-h-3-receptors-and-cholinesterases
#30
JOURNAL ARTICLE
Beata Michalska, Marek Dzięgielewski, Justyna Godyń, Tobias Werner, Marek Bajda, Tadeusz Karcz, Katarzyna Szczepańska, Holger Stark, Anna Więckowska, Krzysztof Walczyński, Marek Staszewski
This study examines the properties of a novel series of 4-oxypiperidines designed and synthesized as histamine H3 R antagonists/inverse agonists based on the structural modification of two lead compounds, viz., ADS003 and ADS009 . The products are intended to maintain a high affinity for H3 R while simultaneously inhibiting AChE or/and BuChE enzymes. Selected compounds were subjected to h H3 R radioligand displacement and gp H3 R functional assays. Some of the compounds showed nanomolar affinity. The most promising compound in the naphthalene series was ADS031 , which contained a benzyl moiety at position 1 of the piperidine ring and displayed 12...
March 5, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38438025/fate-of-pharmaceutical-residue-in-two-romanian-rivers-receiving-treated-water-occurrence-distribution-and-risk-assessment
#31
JOURNAL ARTICLE
Florentina Laura Chiriac, Iuliana Paun, Vasile-Ion Iancu, Florinela Pirvu, Cristina Dinu, Marcela Niculescu, Valentina Andreea Petre
This study presents the first set of data on the removal of proton pump inhibitors (PPIs) and histamine H2 receptor antagonists (HRAs) and their transformation products in two Romanian wastewater treatment plants (WWTPs), as well as the impact of these organic pollutants on freshwater receiving effluents. The research investigated eight target pharmaceuticals and three metabolites using a newly developed and validated Liquid Chromatography - Mass Spectrometry (LC-MS/MS) method. The combined determination had a range of quantification limits varying from 0...
March 2, 2024: Science of the Total Environment
https://read.qxmd.com/read/38435847/new-flavonoids-with-multiple-bronchodilator-activity-pathways-from-tephrosia-purpurea-l-pers-growing-in-saudi-arabia
#32
JOURNAL ARTICLE
Maged S Abdel-Kader, Abdulaziz S Saeedan, Najeeb U Rehman, Hayder M Faqihi, Gamal A Soliman
Total extract of Tephrosia purpurea ( T. purpurea ) expressed potent ex-vivo bronchodilator effect in isolated Guinea pigs' tracheal muscles. Fractionation of T. purpurea total extract ( TPTE) using liquid-liquid technique followed by ex-vivo bronchodilator testing indicated that the activity was trapped to the chloroform (CHCl3 ) soluble fraction. Phytochemical study of the CHCl3 fraction guided by ex-vivo bronchodilator activity led to the isolation of 7 active flavones of which compounds 1 ( epi- Tephroapollin G), 3 (Acetyltephroapollin C), 4 (4''-Dehydroxytephroapollin E), and 5 ( epi- Tephroapollin F) were new...
April 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38432205/associations-between-proton-pump-inhibitor-usage-allergy-and-asthma-an-analysis-of-nhanes-2005-2006
#33
JOURNAL ARTICLE
Ruili Yu, Xueyan Wang, Hongtian Wang, Xuechun Lu, Bo Yang
INTRODUCTION: Acid suppression medications, such as proton-pump inhibitors (PPIs) and histamine-2 receptor antagonists, are commonly prescribed for the treatment of gastroesophageal reflux disease and other gastrointestinal disorders. However, concerns regarding potential long-term side effects are brought up by the overuse of PPIs. This study aimed to investigate the relationship between PPI usage, allergy, and asthma in the general US population. METHODS: Data of individuals aged ≥20 years who had information on PPI use and questionnaires on allergy and asthma in the US National Health and Nutrition Examination Survey (NHANES) 2005-2006 were analyzed...
March 1, 2024: International Archives of Allergy and Immunology
https://read.qxmd.com/read/38418462/cryo-em-structure-of-cell-free-synthesized-human-histamine-2-receptor-g-s-complex-in-nanodisc-environment
#34
JOURNAL ARTICLE
Zoe Köck, Kilian Schnelle, Margherita Persechino, Simon Umbach, Hannes Schihada, Dovile Januliene, Kristian Parey, Steffen Pockes, Peter Kolb, Volker Dötsch, Arne Möller, Daniel Hilger, Frank Bernhard
Here we describe the cryo-electron microscopy structure of the human histamine 2 receptor (H2 R) in an active conformation with bound histamine and in complex with Gs heterotrimeric protein at an overall resolution of 3.4 Å. The complex was generated by cotranslational insertion of the receptor into preformed nanodisc membranes using cell-free synthesis in E. coli lysates. Structural comparison with the inactive conformation of H2 R and the inactive and Gq -coupled active state of H1 R together with structure-guided functional experiments reveal molecular insights into the specificity of ligand binding and G protein coupling for this receptor family...
February 28, 2024: Nature Communications
https://read.qxmd.com/read/38398673/combination-of-h1-and-h2-histamine-receptor-antagonists-current-knowledge-and-perspectives-of-a-classic-treatment-strategy
#35
REVIEW
Erwen Kou, Xiaobei Zhang, Baiping Dong, Bo Wang, Yuanjie Zhu
Histamine receptor antagonists, which can bind to specific histamine receptors on target cells, exhibit substantial therapeutic efficacy in managing a variety of histamine-mediated disorders. Notably, histamine H1 and H2 receptor antagonists have been extensively investigated and universally acknowledged as recommended treatment agents for numerous allergic diseases and acid-related disorders, respectively. Historically, the combination of H1 and H2 receptor antagonists has been considered a classic treatment strategy, demonstrating relatively superior efficacy compared with single-drug therapies in the treatment of diverse histamine-mediated diseases...
January 23, 2024: Life
https://read.qxmd.com/read/38393759/discovery-of-novel-steroid-based-histamine-h-3-receptor-antagonists-inverse-agonists
#36
JOURNAL ARTICLE
István Ledneczki, Pál Tapolcsányi, Eszter Gábor, János Éles, Júlia Barabás, Zoltán Béni, Balázs Varga, Ottilia Balázs, Viktor Román, László Fodor, Judit Szikra, Mónika Vastag, György Lévay, Éva Schmidt, Balázs Lendvai, István Greiner, Béla Kiss, Zsolt Némethy, Sándor Mahó
Steroid-based histamine H3 receptor antagonists (d-homoazasteroids) were designed by combining distinct structural elements of HTS hit molecules. They were characterized, and several of them displayed remarkably high affinity for H3 receptors with antagonist/inverse agonist features. Especially, the 17a-aza-d-homolactam chemotype demonstrated excellent H3 R activity together with significant in vivo H3 antagonism. Optimization of the chemotype was initiated with special emphasis on the elimination of the hERG and muscarinic affinity...
February 23, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38393344/interleukin-19-enhances-eosinophil-infiltration-through-upregulation-of-epithelium-derived-rantes-expression-via-the-erk-nf-%C3%AE%C2%BAb-signalling-pathway-in-patients-with-eosinophilic-crswnp
#37
JOURNAL ARTICLE
Zizhen Huang, Xia Li, Yue Li, Weiqiang Huang, Xiaoping Lai, Haotian Wu, Xiaohong Chen, Yana Zhang, Lihong Chang, Gehua Zhang
BACKGROUD: The recurrence rate of chronic rhinosinusitis with nasal polyps (CRSwNP) is positively correlated with eosinophil infiltration. Increased interleukin (IL)-19 and eosinophil chemokine RANTES levels have been reported in patients with CRSwNP. This study aimed to clarify the role of IL-19 in mediating RANTES expression and eosinophilic infiltration in eosinophilic CRSwNP (Eos CRSwNP). METHODS: Nasal tissue samples were obtained from patients with CRSwNP and controls...
February 23, 2024: Inflammation Research: Official Journal of the European Histamine Research Society ... [et Al.]
https://read.qxmd.com/read/38387718/pharmacological-characterization-of-seven-human-histamine-h-3-receptor-isoforms
#38
JOURNAL ARTICLE
Meichun Gao, Mabel E Dekker, Rob Leurs, Henry F Vischer
The histamine H3 receptor (H3 R) regulates as a presynaptic G protein-coupled receptor the release of histamine and other neurotransmitters in the brain, and is consequently a potential therapeutic target for neuronal disorders. The human H3 R encodes for seven splice variants that vary in the length of intracellular loop 3 and/or the C-terminal tail but are all able to induce heterotrimeric Gi protein signaling. The last two decades H3 R drug discovery and lead optimization has been exclusively focused on the 445 amino acids-long reference isoform H3 R-445...
February 20, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38386393/the-efficacy-of-bepotastine-besilate-compared-with-hydroxyzine-pamoate-for-preventing-infusion-reactions-to-the-first-dose-of-rituximab-in-patients-with-non-hodgkin-lymphoma-protocol-for-a-phase-ii-double-blind-multicenter-randomized-trial
#39
JOURNAL ARTICLE
Yumi Kitahiro, Kazuhiro Yamamoto, Kimikazu Yakushijin, Takeshi Ioroi, Masaaki Tanda, Kotaro Itohara, Tomohiro Omura, Hironobu Minami, Ikuko Yano
BACKGROUND: Rituximab, an anti-CD20 monoclonal antibody, can cause infusion reactions (IRs), especially during the initial rituximab infusion therapy. Generally, patients are administered a histamine H1 -receptor antagonist before the rituximab infusion, along with an antipyretic analgesic, to prevent or reduce IRs. Multiple retrospective case-control studies indicate that the second generation of histamine H1 -receptor antagonists might be more effective than the first generation in suppressing IRs caused by the rituximab infusion...
February 22, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38373256/histamine-3-receptor-availability-and-glutamate-levels-in-the-brain-a-pet-1h-mrs-study-of-patients-with-schizophrenia-and-healthy-controls
#40
JOURNAL ARTICLE
Atheeshaan Arumuham, Matthew M Nour, Mattia Veronese, Katherine Beck, Ellis Chika Onwordi, David J Lythgoe, Sameer Jauhar, Eugenii A Rabiner, Oliver D Howes
BACKGROUND: The histamine-3 receptor (H3R) may have a role in cognitive processes, through its action as a presynaptic heteroreceptor inhibiting the release of glutamate in the brain. To explore this, we examined anterior cingulate cortex (ACC) and striatum H3R availability in patients with schizophrenia, and characterised their relationships with glutamate levels in corresponding brain regions. METHODS: We employed a cross-sectional study, recruiting 12 patients with schizophrenia and 12 healthy volunteers...
February 19, 2024: International Journal of Neuropsychopharmacology
keyword
keyword
80879
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.